Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Discover the best cryptocurrencies for beginners. Start your investment journey with these user-friendly options.
5,516 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
In a late-day turn, Bill Gates pulled out of India’s AI Impact Summit hours before his keynote, amplifying concerns o...
Tempus AI shares rose as it introduced an AI-powered HRD-RNA cancer diagnostic algorithm, signaling momentum before i...
XLY relies heavily on two megacaps, exposing the fund to outsized moves from Amazon and Tesla and prompting renewed q...
Crypto hedge funds started 2026 with losses as volatility rose, prompting a shift to market-neutral and relative-valu...
A pricing glitch in Moonwell's oracle feed sparked a wave of liquidations, leaving roughly $1.8 million in bad debt. ...
Pi Network pushed through a February deadline with few updates, fueling community scrutiny while markets react. This ...
Pippin (PIPPIN) erased most of its recent gains with a sharp 20% drop in a single day, sending the meme coin into a r...
An AI-driven forecast suggests XRP, DOGE and SOL could test new all-time highs by the end of 2026, underscoring evolv...
Feb. 18, 2026 — XRP, Solana, and Dogecoin are at the center of a quiet yet active market as traders weigh catalysts a...
When expenses shrink, choices grow. A lower cost of living can turn basic stability into genuine freedom—time for fam...
XRP faces a steep pullback even as investor chatter surges. Grayscale’s sentiment report brands XRP as the second-mos...